Furthermore, we validated these findings in digestive tumors, demonstrating that ETV4 expression was closely related to tumor cell proliferation, migration, and apoptosis, and significantly influences the expression of immune-related molecules, highlighting its potential impact on immunotherapy treatments. The gene discussed is ETV4; the disease is digestive system neoplasm.